Skip to main content
EJNMMI Research
Figure 1 | EJNMMI Research

Figure 1

From: Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients

Figure 1

Kaplan-Meier curves for response assessment by conventional imaging modalities and positron emission tomography. Progression-free survival according to the information provided by the response assessment using (A) conventional imaging modalities in accordance to the recommendations given by Cheson et al. [11], (B) visual response assessment of interim PET using the recommendations given by Juweid et al. on behalf of the IHP [14], and (C) relative decrease in SUVmax between baseline and interim PET. PFS, progression-free survival; CR, complete response; CRu, complete response unconfirmed; PR, partial response; SD, stable disease; Δ SUVmax, decrease in maximum standardized uptake value between staging and interim PET; neg., negative; pos., positive.

Back to article page